Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study | Synapse
May 23, 2024Open Access
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
Key Points
Key points are not available for this paper at this time.
Abstract
For the French translation of the abstract see Supplementary Materials section.